NCT00171665已完成3 期
Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Novartis
- 入组人数
- 360
- 试验地点
- 138
- 主要终点
- OA pain intensity in target hand at Week 4 and 6
研究概览
简要总结
This study will test the efficacy and safety of topical diclofenac sodium gel in the treatment of hand osteoarthritis.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 40 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Osteoarthritis of the hand
排除标准
- •Other rheumatic disease, such as rheumatoid arthritis
- •Active gastrointestinal ulcer during the last year
- •Known allergy to analgesic drugs
结局指标
主要结局
OA pain intensity in target hand at Week 4 and 6
Global rating of disease activity by patient at Week 4 and 6
Total AUSCAN score in target hand at Week 4 and 6
次要结局
- Global evaluation of treatment at final visit
- AUSCAN pain, stiffness and physical function scores in target hand, and global rating of benefit by patient at Weeks 1, 2, 4, 6 and 8
- OA pain intensity and total AUSCAN score in target hand, and global rating of disease activity by patient at Weeks 1, 2 and 8
- OA pain intensity in target hand and use of rescue medication recorded in diary
- Treatment responder rate according to OARSI criteria
研究者
研究点 (138)
Loading locations...
相似试验
已完成
3 期
Efficacy and Safety of Diclofenac Sodium Gel in Hand OsteoarthritisOsteoarthritisNCT00171652Novartis360
已完成
3 期
Efficacy and Safety of Diclofenac Sodium Gel in Knee OsteoarthritisOsteoarthritisNCT00171626Novartis480
已完成
3 期
Efficacy and Safety of Diclofenac Sodium Gel in Knee OsteoarthritisOsteearthritisNCT00171678Novartis480
已完成
3 期
Study Comparing a Generic Diclofenac Sodium Topical Gel, 1% to Voltaren in the Treatment of Subjects With Osteoarthritis of the KneeOsteoarthritisNCT02121002Amneal Pharmaceuticals, LLC1,176
已完成
3 期
Efficacy and Safety of Topical Diclofenac Combined With Oral Diclofenac in the Treatment of Knee OsteoarthritisOsteoarthritis, KneeNCT00108992Nuvo Research Inc.750
